Literature DB >> 16887242

Adjuvant activity of Quillaja brasiliensis saponins on the immune responses to bovine herpesvirus type 1 in mice.

Juliane D Fleck1, Carla Kauffmann, Fernando Spilki, Claiton L Lencina, Paulo M Roehe, Grace Gosmann.   

Abstract

The chemical characterization of aqueous extracts (AE) of barks, leaves and branches and the saponin fraction denominated QB-90 obtained from Quillaja brasiliensis, a native species from Southern Brazil, show remarkable similarities to Quillaja saponaria saponins which are known as adjuvants in vaccine formulations. In vivo toxicity assays of AE and QB-90 showed not to be lethal for mice in doses ranging from 50 to 1600 microg and 50-400 microg, respectively. Experimental vaccines prepared with bovine herpesvirus type 1 (BHV-1) antigen and either AE (barks 100 microg, leaves 400 microg, branches 400 microg) or QB-90 (100 microg) were able to enhance the immune responses of mice in a comparable manner to saponins from Q. saponaria (QuilA, 100 microg). BHV-1 specific IgG, IgG1 and IgG2a antibody levels in serum were also significantly enhanced by AE, QB-90 and QuilA compared to control group (p<0.05). These results showed that AE and QB-90 from Q. brasiliensis are potential candidates as adjuvants in vaccines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16887242     DOI: 10.1016/j.vaccine.2006.06.059

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

1.  Combining Monophosphoryl Lipid A (MPL), CpG Oligodeoxynucleotide (ODN), and QS-21 Adjuvants Induces Strong and Persistent Functional Antibodies and T Cell Responses against Cell-Traversal Protein for Ookinetes and Sporozoites (CelTOS) of Plasmodium falciparum in BALB/c Mice.

Authors:  Sakineh Pirahmadi; Sedigheh Zakeri; Akram A Mehrizi; Navid D Djadid; Abbas-Ali Raz; Jafar J Sani
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

2.  Characterization of in vivo anti-rotavirus activities of saponin extracts from Quillaja saponaria Molina.

Authors:  Ka Ian Tam; Michael R Roner
Journal:  Antiviral Res       Date:  2011-04-23       Impact factor: 5.970

3.  Abiotic elicitation of gymnemic acid in the suspension cultures of Gymnema sylvestre.

Authors:  Bhuvaneswari Ch; Kiranmayee Rao; Suryakala Gandi; Archana Giri
Journal:  World J Microbiol Biotechnol       Date:  2011-09-04       Impact factor: 3.312

4.  Anti-Trichomonas vaginalis activity of saponins from Quillaja, Passiflora, and Ilex species.

Authors:  Tábitha Dahmer Rocha; Patrícia de Brum Vieira; Simone Cristina Baggio Gnoatto; Tiana Tasca; Grace Gosmann
Journal:  Parasitol Res       Date:  2012-01-05       Impact factor: 2.289

Review 5.  Production of plant bioactive triterpenoid saponins: elicitation strategies and target genes to improve yields.

Authors:  Anna C A Yendo; Fernanda de Costa; Grace Gosmann; Arthur G Fett-Neto
Journal:  Mol Biotechnol       Date:  2010-09       Impact factor: 2.695

6.  Formulation of IMXQB: Nanoparticles Based on Quillaja brasiliensis Saponins to be Used as Vaccine Adjuvants.

Authors:  Mariana Rivera-Patron; Samuel P Cibulski; Iris Miraballes; Fernando Silveira
Journal:  Methods Mol Biol       Date:  2022

Review 7.  Vaccine adjuvants: current challenges and future approaches.

Authors:  Jennifer H Wilson-Welder; Maria P Torres; Matt J Kipper; Surya K Mallapragada; Michael J Wannemuehler; Balaji Narasimhan
Journal:  J Pharm Sci       Date:  2009-04       Impact factor: 3.534

8.  Triterpenoid saponins from the roots of Acanthophyllum gypsophiloides Regel.

Authors:  Elena A Khatuntseva; Vladimir M Men'shov; Alexander S Shashkov; Yury E Tsvetkov; Rodion N Stepanenko; Raymonda Ya Vlasenko; Elvira E Shults; Genrikh A Tolstikov; Tatjana G Tolstikova; Dimitri S Baev; Vasiliy A Kaledin; Nelli A Popova; Valeriy P Nikolin; Pavel P Laktionov; Anna V Cherepanova; Tatiana V Kulakovskaya; Ekaterina V Kulakovskaya; Nikolay E Nifantiev
Journal:  Beilstein J Org Chem       Date:  2012-05-23       Impact factor: 2.883

9.  Alternative inactivated poliovirus vaccines adjuvanted with Quillaja brasiliensis or Quil-a saponins are equally effective in inducing specific immune responses.

Authors:  Fernanda de Costa; Anna Carolina A Yendo; Samuel P Cibulski; Juliane D Fleck; Paulo M Roehe; Fernando R Spilki; Grace Gosmann; Arthur G Fett-Neto
Journal:  PLoS One       Date:  2014-08-22       Impact factor: 3.240

10.  Quillaja brasiliensis saponin-based nanoparticulate adjuvants are capable of triggering early immune responses.

Authors:  Samuel Paulo Cibulski; Mariana Rivera-Patron; Gustavo Mourglia-Ettlin; Cecilia Casaravilla; Anna Carolina Alves Yendo; Arthur Germano Fett-Neto; José Alejandro Chabalgoity; María Moreno; Paulo Michel Roehe; Fernando Silveira
Journal:  Sci Rep       Date:  2018-09-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.